Polycap LLC, a Toronto-based manufacturer of specialty caps and closures for a number of vertical markets, will invest $7.7 million to establish its first U.S. manufacturing facility in a ...
The Indian Polycap Study (TIPS). Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet ...
BENSALEM, Pa.–(BUSINESS WIRE)–Precision Aerospace Components (the “Company”) (PAOS:OTCPK) and its Board of Directors completed a strategic recapitalization of the Company, on Friday, January 16.
These theoretical projections of benefit are based on extrapolations from studies that involved patients with hypertension or hyperlipidemia, and also on an unvalidated assumption that the magnitude ...
?All over the world, response to the research findings on Polycap is overwhelming. This is a proud moment for me as an Indian that an Indian Pharmaceutical company has worked hard to achieve this feat ...
Polycap LLC, a Toronto-based manufacturer of specialty caps and closures for a number of vertical markets, will invest $7.7 million to establish its first U.S. manufacturing facility in the ...
Most national newspapers have reported on a study of a ‘polypill’ that can “halve” the risk of heart disease and stroke. Brought to you by NHS Choices The Daily Telegraph said the new “five-in-one ...
Cadila Pharmaceuticals Limited, an Ahmedabad based pharma major, has launched world’s first 5-in-1 wonder pill ‘Polycap’ in the domestic market. AHMEDABAD: Cadila Pharmaceuticals Limited, an Ahmedabad ...
Denis Xavier; Prem Pais; Alben Sigamani; Janice Pogue; Rizwan Afzal; Salim Yusuf; on behalf of The Indian Polycap Study (TIPS) Investigators These theoretical projections of benefit are based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results